Syra Health Corp. (SYRA)
OTCMKTS
· Delayed Price · Currency is USD
0.0808
-0.0092 (-10.22%)
May 14, 2025, 12:44 PM EDT
Syra Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 2.49 | 2.4 | 3.28 | 0 | 0.1 | 0 |
Cash & Short-Term Investments | 2.49 | 2.4 | 3.28 | 0 | 0.1 | 0 |
Cash Growth | -23.08% | -26.97% | 97988.37% | -96.66% | 3233.73% | - |
Accounts Receivable | 0.95 | 0.68 | 1.06 | 1.2 | 0.26 | - |
Other Receivables | - | - | 0.07 | 0.15 | 0.02 | - |
Receivables | 0.95 | 0.68 | 1.13 | 1.35 | 0.28 | - |
Prepaid Expenses | - | 0.28 | 0.32 | 0.05 | - | - |
Other Current Assets | 0.21 | - | 0.05 | 0.03 | - | - |
Total Current Assets | 3.65 | 3.35 | 4.78 | 1.43 | 0.38 | 0 |
Property, Plant & Equipment | 0.08 | 0.33 | 0.14 | 0.3 | 0.15 | - |
Long-Term Deferred Charges | - | - | - | 0.6 | - | - |
Total Assets | 3.72 | 3.68 | 4.92 | 2.32 | 0.54 | 0 |
Accounts Payable | 0.33 | 0.1 | 0.46 | 0.43 | 0.13 | - |
Accrued Expenses | 0.21 | 0.23 | 0.2 | 0.24 | 0.05 | 0 |
Short-Term Debt | 0.08 | 0.15 | 0.18 | 0.75 | 0.19 | 0 |
Current Portion of Leases | 0.05 | 0.11 | 0.06 | 0.12 | 0.06 | - |
Current Unearned Revenue | 0.6 | 0.02 | - | - | - | - |
Other Current Liabilities | - | - | - | - | 0.03 | - |
Total Current Liabilities | 1.27 | 0.61 | 0.91 | 1.55 | 0.45 | 0.01 |
Long-Term Leases | - | 0.19 | - | 0.06 | 0.09 | - |
Total Liabilities | 1.27 | 0.8 | 0.91 | 1.61 | 0.54 | 0.01 |
Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 |
Additional Paid-In Capital | 11.74 | 11.69 | 9.07 | 2.83 | 0 | - |
Retained Earnings | -9.3 | -8.82 | -5.06 | -2.13 | -0.01 | -0.01 |
Shareholders' Equity | 2.46 | 2.88 | 4.01 | 0.71 | -0.01 | -0 |
Total Liabilities & Equity | 3.72 | 3.68 | 4.92 | 2.32 | 0.54 | 0 |
Total Debt | 0.13 | 0.45 | 0.25 | 0.93 | 0.34 | 0 |
Net Cash (Debt) | 2.36 | 1.94 | 3.03 | -0.93 | -0.24 | - |
Net Cash Growth | -24.02% | -35.91% | - | - | - | - |
Net Cash Per Share | 0.27 | 0.26 | 0.62 | -0.31 | -0.29 | - |
Filing Date Shares Outstanding | 71.34 | 17.31 | 14.06 | 11.9 | 11.9 | 13.75 |
Total Common Shares Outstanding | 71.34 | 17.31 | 13.92 | 11.9 | 8.33 | 13.75 |
Working Capital | 2.38 | 2.74 | 3.87 | -0.12 | -0.07 | -0 |
Book Value Per Share | 0.03 | 0.17 | 0.29 | 0.06 | -0.00 | -0.00 |
Tangible Book Value | 2.46 | 2.88 | 4.01 | 0.71 | -0.01 | -0 |
Tangible Book Value Per Share | 0.03 | 0.17 | 0.29 | 0.06 | -0.00 | -0.00 |
Machinery | - | 0.09 | 0.08 | 0.13 | 0.01 | - |
Leasehold Improvements | - | 0.06 | 0.06 | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.